Leber Congenital Amaurosis 5-Like (LCA5L) (Middle Region) Peptid
LCA5L
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LCA5L Produkte
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-C21orf13 antibody (Catalog #: ARP45911_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Synonyme
- C21orf13 Peptide, 4921526F01Rik Peptide, Lcca5l Peptide, Leber congenital amaurosis 5-like Peptide, LCA5L, lebercilin like Peptide, LCA5L Peptide, Lca5l Peptide
- Hintergrund
-
The function of the C21orf13 protein remains unknown.
Alias Symbols: MGC33295, C21orf13
Protein Size: 670 - Molekulargewicht
- 76 kDa
- Gen-ID
- 150082
- NCBI Accession
- NM_152505, NP_689718
- UniProt
- O95447
-
Sie sind hier:
